Back

Incorporating New Data Into Patient Care for Lupus Nephritis

Join the faculty for a lively and engaging discussion on the management of LN. This will include the rationale for targeting B cells, presentation of the latest clinical data, new guidelines from the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR), and how clinicians are incorporating B-cell targeting treatments into therapy for patients with LN.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1.25 credits
  • Commercial Support
  • Released
    Nov 24, 2025
  • Last day to claim credit
    Nov 25, 2026 6 weeks left